Navigation Links
Short Course of Hormone Therapy Boosts Prostate Cancer Survival: Study
Date:3/25/2011

By Steven Reinberg
HealthDay Reporter

THURSDAY, March 24 (HealthDay News) -- Just six months of hormone therapy, along with radiation, cuts the risk of dying from locally advanced prostate cancer in half when compared to radiation alone, researchers report.

Just as important, the study indicates that a short course of hormone therapy has few of the side effects seen with longer treatment regimens of two to three years.

Hormone therapy in men, also known as androgen-deprivation therapy, lowers levels of the male hormones that encourage prostate cancer to grow.

"A halving of the risk of dying from these more advanced prostate cancers clearly has very major significance for men affected," said researcher Dr. David Lamb, director of the Prostate Cancer Trials Unit at the University of Otago in Wellington, New Zealand.

"Early diagnosis of prostate cancer remains the goal, but at least men presenting with more advanced tumors can now be offered treatment proven to have a much better chance of cure," he said.

The report is published in the March 24 online edition of The Lancet Oncology.

As part of the Trans-Tasman Radiation Oncology Group trial, Lamb's group randomly assigned 802 men with locally advanced prostate cancer to radiation alone, or three months of hormone therapy plus radiation, or six months of hormone therapy and radiation.

Over an average of 10.6 years of follow-up, men who received six months of hormone therapy and radiation were significantly less likely to die from prostate cancer than men who had radiation alone -- 11 percent vs. 22 percent, respectively. They were also much less likely to die from any cause -- 29 percent vs. 43 percent, the researchers found.

Hormone therapy over three months had no effect on the spread of prostate cancer, or dying from the cancer or any other cause, compared with radiation alone, Lamb's team noted.

Compared to a six-month bout of the hormone therapy, androgen-deprivation therapy over an extended period can result in serious side effects, including erectile dysfunction, hot flashes, fatigue, osteoporosis, high cholesterol, anemia and cardiac death.

"This study with locally advanced prostate cancers has shown that adding [just] six months of hormone treatment to radiotherapy halves the numbers of deaths from prostate cancer in the next 10 years," Lamb said.

"Whilst there were already known to be benefits from short-term hormone treatment in this group of patients, this is the first trial to demonstrate the magnitude of long-term benefits. A 50 percent improvement in survival is a massive gain, and it was achieved with relatively few extra side effects for patients," he added.

Prostate cancer expert Dr. Anthony D'Amico, chief of radiation oncology at Brigham and Women's Hospital in Boston, said this study validates his own research, which showed that six months of hormone therapy plus radiation prolonged survival.

"You get an overall survival benefit when you add six months of hormone therapy to radiation in men with high-risk prostate cancer," he said. "Six months of hormonal therapy with radiation is a valid treatment option with high-risk prostate cancer."

Men may choose to have longer hormone treatment, D'Amico said. However, survival will probably only marginally improve, and there is a risk for heart problems with the prolonged use of hormone therapy, he said.

More information

For more information on prostate cancer, visit the American Cancer Society.

SOURCES: David Lamb, M.B., F.R.C.P., director, Prostate Cancer Trials Unit, University of Otago, Wellington, New Zealand; Anthony D'Amico, M.D., Ph.D, chief, radiation oncology, Brigham and Women's Hospital, Boston; March 24, 2011, The Lancet Oncology, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. American Council on Exercise (ACE) Study Reveals Kettlebells Provide Powerful Workout in Short Amount of Time
2. For Some Breast Cancer Patients, Shorter Radiation Works Well
3. Short-term radiation therapy successful on breast cancer
4. No End In Sight To The Armour Thyroid Shortage?
5. WHI data confirm short-term heart disease risks of combination menopausal hormone therapy
6. Americans Falling Short on Heart-Healthy Fruits and Vegetables
7. Website for Nursing Jobs Launches -- Streamlined Job Board Created to Address Nursing Shortage
8. Los Angeles Jewish Home Adds Short-Term Rehabilitative Care to Family of Services
9. Newer cornea transplant surgery shows short- and long-term promise
10. Short on specialized intensive care physicians, team-based approach improves ICU outcomes
11. Apex Heart Care, First Arizona Clinic to Install Shape-HF; New Medical Device Measures Patient Physiology to Define Shortness of Breath
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Short Course of Hormone Therapy Boosts Prostate Cancer Survival: Study
(Date:10/13/2017)... ... , ... Talented host, actor Rob Lowe, is introducing a ... episode of "Success Files," which is an award-winning educational program broadcasted on PBS ... in-depth with passion and integrity. , Sciatica occurs when the sciatic nerve in ...
(Date:10/12/2017)... ... 2017 , ... First Healthcare Compliance (FHC), an industry leader ... range of technology and learning solutions at the 68th Annual American Healthcare Association ... held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, Nevada. ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... today the introduction of an innovative new design of the shoulder pad. The ... get maximum comfort while controlling your pain while using cold therapy. By utilizing ice ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the ... medical article to the newly revamped Cosmetic Town journal section, featuring ... transplant procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand Rapids-based workplace ... Brightest in Wellness® by Best and Brightest. OnSite Wellness will be honored at ... from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, located ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Fla. , Oct. 2, 2017  AllianceRx Walgreens ... company formed by Walgreens and pharmacy benefit manager Prime ... its new brand, which included the unveiling of new ... , as well as at a few other ... the new brand to patients, some of whom will ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
Breaking Medicine Technology: